Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS SUN PHARMA DECIPHER LABS/
SUN PHARMA
 
P/E (TTM) x -2.1 43.2 - View Chart
P/BV x 0.6 6.9 9.3% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DECIPHER LABS   SUN PHARMA
EQUITY SHARE DATA
    DECIPHER LABS
Mar-23
SUN PHARMA
Mar-23
DECIPHER LABS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs631,072 5.9%   
Low Rs14790 1.8%   
Sales per share (Unadj.) Rs45.1182.9 24.7%  
Earnings per share (Unadj.) Rs-2.735.7 -7.4%  
Cash flow per share (Unadj.) Rs-2.246.2 -4.8%  
Dividends per share (Unadj.) Rs011.50 0.0%  
Avg Dividend yield %01.2 0.0%  
Book value per share (Unadj.) Rs23.0233.4 9.8%  
Shares outstanding (eoy) m10.102,399.34 0.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.95.1 16.8%   
Avg P/E ratio x-14.526.1 -55.6%  
P/CF ratio (eoy) x-17.320.1 -85.7%  
Price / Book Value ratio x1.74.0 42.0%  
Dividend payout %032.2 -0.0%   
Avg Mkt Cap Rs m3892,233,361 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m41282,960 0.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m456438,857 0.1%  
Other income Rs m748,199 0.9%   
Total revenues Rs m529447,055 0.1%   
Gross profit Rs m-106112,900 -0.1%  
Depreciation Rs m425,294 0.0%   
Interest Rs m51,720 0.3%   
Profit before tax Rs m-4294,084 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-158,476 -0.2%   
Profit after tax Rs m-2785,608 -0.0%  
Gross profit margin %-23.325.7 -90.6%  
Effective tax rate %35.59.0 394.2%   
Net profit margin %-5.919.5 -30.2%  
BALANCE SHEET DATA
Current assets Rs m201398,619 0.1%   
Current liabilities Rs m50199,064 0.0%   
Net working cap to sales %33.245.5 73.0%  
Current ratio x4.12.0 202.4%  
Inventory Days Days30147 20.5%  
Debtors Days Days78995 829.6%  
Net fixed assets Rs m71376,960 0.0%   
Share capital Rs m1012,399 4.2%   
"Free" reserves Rs m131557,555 0.0%   
Net worth Rs m232559,954 0.0%   
Long term debt Rs m00-   
Total assets Rs m272775,794 0.0%  
Interest coverage x-7.655.7 -13.7%   
Debt to equity ratio x00-  
Sales to assets ratio x1.70.6 296.6%   
Return on assets %-8.111.3 -72.0%  
Return on equity %-11.615.3 -75.6%  
Return on capital %-15.817.1 -92.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0154,053 0.0%   
Fx outflow Rs m071,511 0.0%   
Net fx Rs m082,541 0.0%   
CASH FLOW
From Operations Rs m-1649,593 -0.0%  
From Investments Rs m-43-79,437 0.1%  
From Financial Activity Rs m-2223,761 -0.1%  
Net Cashflow Rs m-801,155 -6.9%  

Share Holding

Indian Promoters % 0.0 54.5 -  
Foreign collaborators % 16.4 0.0 -  
Indian inst/Mut Fund % 0.0 36.6 -  
FIIs % 0.0 17.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 83.6 45.5 183.6%  
Shareholders   34,511 612,626 5.6%  
Pledged promoter(s) holding % 0.0 2.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on COMBAT DRUGS vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

COMBAT DRUGS vs Sun Pharma Share Price Performance

Period COMBAT DRUGS Sun Pharma S&P BSE HEALTHCARE
1-Day 0.68% 0.77% 1.18%
1-Month -17.62% 3.00% -0.75%
1-Year -1.07% 64.65% 61.82%
3-Year CAGR -24.12% 39.45% 18.16%
5-Year CAGR -10.83% 27.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the COMBAT DRUGS share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of COMBAT DRUGS hold a 16.4% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of COMBAT DRUGS and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, COMBAT DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of COMBAT DRUGS, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.